Can Age Affect Response to Immune Checkpoint Inhibitors?

A new study has linked age with how well patients with melanoma responded to treatment with immune checkpoint inhibitors. Experiments in mice suggested that the response pattern may be due to an age-related shift in the kinds of immune cells in tumors.

Cancer Currents: An NCI Cancer Research Blog